Patent details

Basic Information

Publication number:

EP3315500

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171834732

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FUSED TETRA OR PENTA-CYCLIC DIHYDRODIAZEPINOCARBAZOLONES AS PARP INHIBITORS

French Title of Invention:

DIHYDRODIAZEPINOCARBAZOLONES TÉTRA OU PENTACYCLIQUES FUSIONNÉS COMME INHIBITEURS DE PARP

German Title of Invention:

KONDENSIERTE TETRA- ODER PENTACYCLISCHE DIHYDRODIAZEPINCARBAZOLONE ALS PARP-INHIBITOREN

SPC Number:

Dates

Filing date:

31/12/2011

Grant date:

18/03/2020

EP Publication Date:

02/05/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/03/2020

EP B1 Publication Date:

18/03/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/12/2020

Expiration date:

31/12/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/03/2020

 

 

Name:

BeiGene, Ltd.

Address:

Mourant Ozannes, Corporate Services (Cayman) Limited, Harbour Centre 42 North Church Street PO box 1348, Grand Cayman KY1-1108, Cayman Islands (KY)

Inventor

1

Name:

ZHOU, Changyou

Address:

United States (US)

2

Name:

REN, Bo

Address:

China (CN)

3

Name:

WANG, Hexiang

Address:

China (CN)

Classification

IPC classification:

A61K 31/55; A61K 31/551; A61P 29/00; A61P 35/00; A61P 37/00; C07D 487/06; C07D 487/16;

Publication

European Patent Bulletin

Issue number:

202012

Publication date:

18/03/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages